Harrow, Inc. Gain (Loss) on Investments
Harrow, Inc. (HROW) reported Gain (Loss) on Investments of -$3.17 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-03-02
- Harrow, Inc. gain (loss) on investments for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Harrow, Inc. gain (loss) on investments for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Harrow, Inc. gain (loss) on investments for the quarter ending 2024-06-30 was -$1.92M.
- Harrow, Inc. gain (loss) on investments for the quarter ending 2024-03-31 was -$1.25M, a 161.12% decline year-over-year.
- Harrow, Inc. gain (loss) on investments for fiscal 2024 was -$3.17M, a 202.55% decline from fiscal 2023.
- Harrow, Inc. gain (loss) on investments for fiscal 2023 was $3.09M.
- Harrow, Inc. gain (loss) on investments for fiscal 2022 was -$2.91M.
- Harrow, Inc. gain (loss) on investments for fiscal 2021 was -$10.13M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | -$1.92M derived: sum of 3 quarters · filed 2026-03-02 | -$3.17M 10-K · filed 2026-03-02 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.92M derived: sum of 2 quarters · filed 2025-11-10 | -$3.17M 10-Q · filed 2025-11-10 | -$2.75M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$1.92M 10-Q · filed 2025-08-11 | -$3.17M 10-Q · filed 2025-08-11 | -$2.75M derived: sum of 3 quarters · filed 2026-03-02 | -$1.41M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$1.25M 10-Q · filed 2025-05-08 | -$832.00K derived: sum of 2 quarters · filed 2026-03-02 | $516.00K derived: sum of 3 quarters · filed 2026-03-02 | -$198.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.76M derived: sum of 2 quarters · filed 2026-03-02 | $1.05M derived: sum of 3 quarters · filed 2026-03-02 | $3.09M 10-K · filed 2026-03-02 |
| 2023-09-30 | $1.35M 10-Q · filed 2024-11-14 | $634.00K derived: sum of 2 quarters · filed 2024-11-14 | $2.68M 10-Q · filed 2024-11-14 | $4.10M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$714.00K 10-Q · filed 2024-08-07 | $1.33M 10-Q · filed 2024-08-07 | $2.75M derived: sum of 3 quarters · filed 2024-08-07 | $1.72M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $2.04M 10-Q · filed 2024-05-13 | $3.47M derived: sum of 2 quarters · filed 2024-05-13 | $2.44M derived: sum of 3 quarters · filed 2024-05-13 | -$1.01M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $396.00K derived: sum of 2 quarters · filed 2024-03-19 | -$3.05M derived: sum of 3 quarters · filed 2024-03-19 | -$2.91M 10-K · filed 2024-03-19 |
| 2022-09-30 | -$1.03M 10-Q · filed 2023-11-13 | -$4.48M derived: sum of 2 quarters · filed 2023-11-13 | -$4.34M 10-Q · filed 2023-11-13 | -$5.83M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$3.45M 10-Q · filed 2023-08-09 | -$3.31M 10-Q · filed 2023-08-09 | -$4.80M derived: sum of 3 quarters · filed 2023-08-09 | -$7.02M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $139.00K 10-Q · filed 2023-05-11 | -$1.35M derived: sum of 2 quarters · filed 2023-05-11 | -$3.57M derived: sum of 3 quarters · filed 2023-05-11 | -$7.15M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$3.71M derived: sum of 2 quarters · filed 2023-03-23 | -$7.29M derived: sum of 3 quarters · filed 2023-03-23 | -$10.13M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$2.22M 10-Q · filed 2022-11-14 | -$5.80M derived: sum of 2 quarters · filed 2022-11-14 | -$8.64M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$3.58M 10-Q · filed 2022-08-09 | -$6.42M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$2.83M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |